![Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer](https://oncodaily.com/pub/uploads/2024/04/Memorial-Sloan-Kettering-Radiation-Oncology-2.jpg)
Photo from Memorial Sloan Kettering Radiation Oncology/X
Apr 8, 2024, 12:28
Memorial Sloan Kettering Radiation Oncology – Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer
Memorial Sloan Kettering Radiation Oncology shared on X:
“New in International Journal of Radiation Oncology, Biology, Physics: Phase II trial shows the rate of implant failure in reconstructed patients with breast cancer treated with IMRT was similar to, but not improved over, conventional, 3D-conformal radiation. Breast cancer serial MRIs may detect early capsular contracture.”
Proceed to the article.
Source: Memorial Sloan Kettering Radiation Oncology/X